FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems

Links shared publicly online about this topic.

  • 1,631
    total visits

FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems

fda.gov

The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.

View full resource at fda.gov

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Urinary System, Drug, Byetta

  • Share

Most Recently Shared on November 2, 2009 at 10:40 pm By:

KQEDhealth KQED Public Radio

"Lizard Spit" #drug, Byetta (4 #diabetes), may cause kidney damage; FDA revises label after 78 reports in 3 yrs. http://ow.ly/yJb7 #pharma

2 years ago...

Also Shared By:

AACE AACE

FDA Alert: Byetta (exenatide) - Renal Failure

drugs.com — “FDA Alert: Byetta (exenatide) - Renal FailureView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 3, 2009 at 1:16 am By:

drugscom Drugs.com Health Site

FDA Alert - Byetta Label Revised to Include Safety Information on Possible Kidney Problems - http://bit.ly/2KuyKU

2 years ago...

Advertisement